Literature DB >> 21468699

IL-8-251A>T polymorphism is associated with breast cancer risk: a meta-analysis.

Qiang Huang1, Cheng Wang, Lu-Jun Qiu, Feng Shao, Ji-Hai Yu.   

Abstract

OBJECTIVE: IL-8-251A>T polymorphisms have been reported to influence the risk for breast cancer in many studies; however, the results still remain controversial and ambiguous. The aim of this study was to determine more precise estimations for the relationship between IL-8-251A>T polymorphisms and the risk for breast cancer.
METHODS: Electronic searches for all publications were conducted on association between this variant and breast cancer in several databases through November 2010. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of the association. Six studies were identified, including 1,880 breast cancer patients and 2,013 controls.
RESULTS: Overall, no significant associations between IL-8-251A>T polymorphism and breast cancer (codominant model: TA vs. AA OR = 1.075, 95%CI = 0.864-1.337; TT vs. AA, OR = 0.900, 95%CI = 0.598-1.354; dominant model: OR = 1.011, 95%CI = 0.783-1.304; and recessive model: OR = 0.854, 95%CI = 0.623-1.171). In the subgroup analysis by ethnicity, significantly decreased risk was found for Africans (TT vs. AA OR = 0.541; 95%CI = 0.396-0.741; dominant model: OR = 0.737, 95%CI = 0.570-0.953; recessive model: OR = 0.594; 95%CI = 0.459-0.768). In the stratified analysis by control sources, significant association was observed in population-based studies (recessive model: OR = 0.692; 95%CI = 0.566-0.861).
CONCLUSIONS: This meta-analysis suggests the IL-8-251A/T polymorphism is associated with breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468699     DOI: 10.1007/s00432-011-0981-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

Review 1.  Low penetrance genes associated with increased risk for breast cancer.

Authors:  B L Weber; K L Nathanson
Journal:  Eur J Cancer       Date:  2000-06       Impact factor: 9.162

2.  A method for meta-analysis of molecular association studies.

Authors:  Ammarin Thakkinstian; Patrick McElduff; Catherine D'Este; David Duffy; John Attia
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

3.  The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.

Authors:  M Ohyauchi; A Imatani; M Yonechi; N Asano; A Miura; K Iijima; T Koike; H Sekine; S Ohara; T Shimosegawa
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.

Authors:  Ayumu Taguchi; Naoki Ohmiya; Kennosuke Shirai; Nobuyuki Mabuchi; Akihiro Itoh; Yoshiki Hirooka; Yasumasa Niwa; Hidemi Goto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

7.  Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

Authors:  Ulla Vogel; Jane Christensen; Bjørn A Nexø; Håkan Wallin; Søren Friis; Anne Tjønneland
Journal:  Carcinogenesis       Date:  2006-09-06       Impact factor: 4.944

8.  Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.

Authors:  Kaouther Snoussi; Wijden Mahfoudh; Noureddine Bouaouina; Slim Ben Ahmed; A Noureddine Helal; Lotfi Chouchane
Journal:  Hum Immunol       Date:  2006-04-05       Impact factor: 2.850

9.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families.

Authors:  J Hull; A Thomson; D Kwiatkowski
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

10.  Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.

Authors:  E Kamali-Sarvestani; M R Aliparasti; S Atefi
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

View more
  7 in total

1.  DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

Authors:  Shimiao Zhu; Hui Zhang; Yang Tang; Peicai Liu; Jianmin Wang
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.

Authors:  Jin Hyun Park; Mi Young Kim; In Sil Choi; Ji-Won Kim; Jin Won Kim; Keun-Wook Lee; Jin-Soo Kim
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

3.  Positive association between Interleukin-8 -251A > T polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis.

Authors:  Daye Cheng; Yiwen Hao; Wenling Zhou; Yiran Ma
Journal:  Cancer Cell Int       Date:  2013-10-22       Impact factor: 5.722

Review 4.  Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Authors:  Lijun Jing; Li Su; Brian Z Ring
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 5.  Association of IL-8 gene promoter -251 A/T and IL-18 gene promoter -137 G/C polymorphisms with head and neck cancer risk: a comprehensive meta-analysis.

Authors:  Zheng Wang; Zi-Ming Gao; Hai-Bo Huang; Li-Sha Sun; An-Qi Sun; Kai Li
Journal:  Cancer Manag Res       Date:  2018-08-10       Impact factor: 3.989

6.  Association between interleukin 8-251 T/A and +781 C/T polymorphisms and glioma risk.

Authors:  Hao Liu; Ping Mao; Changhou Xie; Wanfu Xie; Maode Wang; Haitao Jiang
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

Review 7.  The CXCL8-CXCR1/2 pathways in cancer.

Authors:  Qian Liu; Anping Li; Yijun Tian; Jennifer D Wu; Yu Liu; Tengfei Li; Yuan Chen; Xinwei Han; Kongming Wu
Journal:  Cytokine Growth Factor Rev       Date:  2016-08-25       Impact factor: 7.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.